Open Call: IMI launches new wave of funding to address Coronavirus
The Innovative Medicines Initiative (IMI) is launching a fast-track call for proposals on the development of therapeutics and diagnostics to tackle current and future coronavirus outbreaks. The call has a budget of EUR 45 million from the EU’s Horizon 2020 research and innovation programme. The funding can support projects of organisations such as universities and small and medium-sized enterprises (SMEs).
IMI is looking for proposals that address:
- The development of treatments to rapidly respond to the current COVID-19 outbreak and/or future coronavirus outbreaks – this could include potential drugs that are already at a very advanced stage of development, or an existing, approved drug that could be ‘repurposed’ to treat COVID-19. It could also include drugs that are in the earlier stages of development, as well as strategies to address drug resistance;
- The development of diagnostic tests to rapidly and reliably identify people infected with the coronavirus that causes COVID-19, and for use in clinical trials of new drugs.
To submit a proposal via the electronic submission system, applicants will need to have an EU Login account and ensure that their organisation is registered as a beneficiary. You can find more information here: https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-21.